Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| I-kappa B Kinase | 11 | 2025 | 51 | 2.980 |
Why?
|
| NF-kappa B | 14 | 2023 | 358 | 2.450 |
Why?
|
| Protein Multimerization | 7 | 2025 | 115 | 2.030 |
Why?
|
| NF-kappa B p50 Subunit | 4 | 2024 | 11 | 1.970 |
Why?
|
| Models, Molecular | 16 | 2025 | 876 | 1.440 |
Why?
|
| Protein Binding | 13 | 2025 | 1082 | 1.280 |
Why?
|
| I-kappa B Proteins | 9 | 2024 | 36 | 1.160 |
Why?
|
| Crystallography, X-Ray | 13 | 2025 | 280 | 1.140 |
Why?
|
| DNA | 9 | 2024 | 592 | 0.990 |
Why?
|
| Interleukin-6 | 2 | 2023 | 165 | 0.820 |
Why?
|
| Skeletal Muscle Myosins | 2 | 2024 | 2 | 0.690 |
Why?
|
| Multiprotein Complexes | 2 | 2020 | 56 | 0.650 |
Why?
|
| Lysophospholipids | 2 | 2011 | 20 | 0.650 |
Why?
|
| Protein Engineering | 2 | 2025 | 49 | 0.640 |
Why?
|
| Protein Structure, Tertiary | 8 | 2019 | 423 | 0.640 |
Why?
|
| Myosin Light Chains | 1 | 2019 | 6 | 0.630 |
Why?
|
| Myosin Heavy Chains | 1 | 2019 | 18 | 0.630 |
Why?
|
| Protein Isoforms | 2 | 2019 | 139 | 0.630 |
Why?
|
| Antibody Specificity | 2 | 2017 | 76 | 0.600 |
Why?
|
| Recombinant Proteins | 4 | 2020 | 518 | 0.580 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 306 | 0.570 |
Why?
|
| Transcription Factor RelA | 7 | 2024 | 42 | 0.560 |
Why?
|
| Leukotrienes | 1 | 2017 | 4 | 0.530 |
Why?
|
| Cysteine | 1 | 2017 | 103 | 0.500 |
Why?
|
| Colitis | 1 | 2017 | 71 | 0.490 |
Why?
|
| Drosophila melanogaster | 4 | 2024 | 193 | 0.480 |
Why?
|
| Protein Conformation | 9 | 2017 | 416 | 0.450 |
Why?
|
| Amino Acid Sequence | 5 | 2024 | 1180 | 0.430 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2011 | 13 | 0.400 |
Why?
|
| Phosphorylation | 7 | 2025 | 986 | 0.380 |
Why?
|
| Myofibrils | 2 | 2024 | 12 | 0.370 |
Why?
|
| Metals | 2 | 2025 | 114 | 0.360 |
Why?
|
| Armadillo Domain Proteins | 1 | 2011 | 4 | 0.350 |
Why?
|
| Humans | 24 | 2025 | 43102 | 0.330 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 70 | 0.330 |
Why?
|
| Structure-Activity Relationship | 4 | 2020 | 506 | 0.320 |
Why?
|
| Sphingosine | 1 | 2009 | 22 | 0.310 |
Why?
|
| Antigen-Antibody Complex | 1 | 2009 | 20 | 0.310 |
Why?
|
| Animals | 18 | 2024 | 16992 | 0.300 |
Why?
|
| Drosophila Proteins | 1 | 2011 | 188 | 0.300 |
Why?
|
| Mutation | 3 | 2024 | 1177 | 0.290 |
Why?
|
| Cell Nucleus | 3 | 2024 | 383 | 0.290 |
Why?
|
| Leucine Zippers | 1 | 2008 | 5 | 0.290 |
Why?
|
| Mutant Proteins | 2 | 2020 | 51 | 0.290 |
Why?
|
| Dimerization | 6 | 2009 | 112 | 0.270 |
Why?
|
| Bacterial Proteins | 3 | 2019 | 595 | 0.260 |
Why?
|
| Solutions | 2 | 2020 | 65 | 0.260 |
Why?
|
| Signal Transduction | 3 | 2023 | 2157 | 0.260 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 213 | 0.250 |
Why?
|
| Enzyme Activation | 3 | 2024 | 462 | 0.240 |
Why?
|
| Nuclear Proteins | 1 | 2008 | 333 | 0.240 |
Why?
|
| ras Proteins | 1 | 2006 | 54 | 0.230 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2016 | 186 | 0.230 |
Why?
|
| Substrate Specificity | 3 | 2025 | 219 | 0.230 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2024 | 13 | 0.210 |
Why?
|
| Polyribonucleotides | 1 | 2004 | 2 | 0.210 |
Why?
|
| Molecular Mimicry | 1 | 2004 | 16 | 0.210 |
Why?
|
| Catalytic Domain | 1 | 2024 | 118 | 0.210 |
Why?
|
| X-Rays | 1 | 2023 | 19 | 0.200 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2024 | 185 | 0.190 |
Why?
|
| Proteins | 1 | 2025 | 382 | 0.190 |
Why?
|
| Isatin | 1 | 2022 | 1 | 0.190 |
Why?
|
| Polyubiquitin | 1 | 2022 | 7 | 0.190 |
Why?
|
| Amino Acids | 1 | 2002 | 148 | 0.180 |
Why?
|
| RNA | 1 | 2004 | 266 | 0.180 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 1542 | 0.180 |
Why?
|
| Binding Sites | 6 | 2021 | 671 | 0.180 |
Why?
|
| Myosins | 2 | 2011 | 35 | 0.180 |
Why?
|
| Muscle, Skeletal | 1 | 2024 | 316 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 62 | 0.160 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 41 | 0.160 |
Why?
|
| Protein Stability | 1 | 2020 | 48 | 0.160 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 206 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 159 | 0.160 |
Why?
|
| Protein Structure, Secondary | 4 | 2011 | 182 | 0.160 |
Why?
|
| Response Elements | 1 | 2019 | 55 | 0.150 |
Why?
|
| Mice | 5 | 2023 | 6644 | 0.150 |
Why?
|
| Genome, Human | 1 | 2019 | 144 | 0.150 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 561 | 0.150 |
Why?
|
| Immune System | 1 | 2019 | 41 | 0.150 |
Why?
|
| Aging | 1 | 2024 | 783 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 415 | 0.140 |
Why?
|
| Coenzymes | 1 | 2018 | 13 | 0.140 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2019 | 188 | 0.140 |
Why?
|
| Permeability | 1 | 2017 | 67 | 0.130 |
Why?
|
| Protein Subunits | 3 | 2008 | 93 | 0.130 |
Why?
|
| Blood Vessels | 1 | 2017 | 36 | 0.130 |
Why?
|
| Immunization | 1 | 2017 | 94 | 0.130 |
Why?
|
| Acute Disease | 1 | 2017 | 155 | 0.130 |
Why?
|
| Metyrapone | 1 | 2016 | 5 | 0.120 |
Why?
|
| Bacillus megaterium | 1 | 2016 | 3 | 0.120 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2016 | 10 | 0.120 |
Why?
|
| Palmitic Acid | 1 | 2016 | 23 | 0.120 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 98 | 0.120 |
Why?
|
| Nuclear Localization Signals | 2 | 2006 | 15 | 0.110 |
Why?
|
| Base Sequence | 2 | 2008 | 983 | 0.110 |
Why?
|
| Marinobacter | 1 | 2013 | 1 | 0.100 |
Why?
|
| Borates | 1 | 2013 | 5 | 0.100 |
Why?
|
| Iron-Binding Proteins | 1 | 2013 | 3 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2006 | 321 | 0.100 |
Why?
|
| Chromatography, Gel | 1 | 2013 | 51 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1019 | 0.100 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 69 | 0.100 |
Why?
|
| Sequence Alignment | 2 | 2011 | 272 | 0.090 |
Why?
|
| Surface Plasmon Resonance | 2 | 2009 | 42 | 0.090 |
Why?
|
| Flight, Animal | 1 | 2011 | 5 | 0.090 |
Why?
|
| Transfection | 1 | 2013 | 532 | 0.090 |
Why?
|
| Transgenes | 1 | 2011 | 65 | 0.090 |
Why?
|
| Kinetics | 3 | 2024 | 695 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1596 | 0.090 |
Why?
|
| Pliability | 1 | 2011 | 5 | 0.090 |
Why?
|
| Scattering, Small Angle | 1 | 2011 | 18 | 0.090 |
Why?
|
| Circular Dichroism | 3 | 2019 | 64 | 0.080 |
Why?
|
| Caenorhabditis elegans | 1 | 2011 | 80 | 0.080 |
Why?
|
| Ligands | 3 | 2025 | 388 | 0.080 |
Why?
|
| Binding Sites, Antibody | 1 | 2009 | 19 | 0.080 |
Why?
|
| Antibody Affinity | 1 | 2009 | 21 | 0.080 |
Why?
|
| Molecular Conformation | 1 | 2009 | 155 | 0.070 |
Why?
|
| Aplysia | 2 | 2006 | 20 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 116 | 0.070 |
Why?
|
| Casein Kinase II | 1 | 2008 | 17 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2024 | 458 | 0.070 |
Why?
|
| Gene Expression | 1 | 2011 | 701 | 0.070 |
Why?
|
| Models, Biological | 2 | 2009 | 712 | 0.070 |
Why?
|
| Serine | 1 | 2008 | 79 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 54 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2011 | 460 | 0.070 |
Why?
|
| Glycine | 1 | 2008 | 47 | 0.070 |
Why?
|
| Receptors, Nicotinic | 2 | 2006 | 114 | 0.070 |
Why?
|
| Calcium | 1 | 2009 | 491 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 526 | 0.060 |
Why?
|
| Receptors, Cholinergic | 1 | 2006 | 28 | 0.060 |
Why?
|
| Elapid Venoms | 1 | 2006 | 16 | 0.060 |
Why?
|
| Acetylcholine | 1 | 2006 | 77 | 0.060 |
Why?
|
| Nicotinic Antagonists | 1 | 2005 | 36 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2003 | 267 | 0.060 |
Why?
|
| Salts | 1 | 2025 | 18 | 0.060 |
Why?
|
| Static Electricity | 1 | 2025 | 86 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2023 | 2676 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2005 | 88 | 0.050 |
Why?
|
| Ankyrin Repeat | 1 | 2004 | 1 | 0.050 |
Why?
|
| Deuterium | 1 | 2004 | 11 | 0.050 |
Why?
|
| Synapses | 1 | 2006 | 185 | 0.050 |
Why?
|
| Hydrogen | 1 | 2004 | 47 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2024 | 81 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 100 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 386 | 0.050 |
Why?
|
| Transcription Factor RelB | 1 | 2023 | 9 | 0.050 |
Why?
|
| Tumor Necrosis Factors | 1 | 2023 | 13 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2023 | 37 | 0.050 |
Why?
|
| Carboplatin | 1 | 2023 | 20 | 0.050 |
Why?
|
| Arginine | 1 | 2002 | 75 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 135 | 0.050 |
Why?
|
| Point Mutation | 1 | 2002 | 98 | 0.050 |
Why?
|
| Peptides | 1 | 2006 | 372 | 0.050 |
Why?
|
| Solvents | 1 | 2002 | 113 | 0.050 |
Why?
|
| 4-Butyrolactone | 1 | 2022 | 13 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 296 | 0.040 |
Why?
|
| Stem Cells | 1 | 2023 | 152 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 154 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 307 | 0.040 |
Why?
|
| Female | 2 | 2023 | 24698 | 0.040 |
Why?
|
| Zinc Sulfate | 1 | 2019 | 2 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2019 | 109 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 570 | 0.040 |
Why?
|
| Ribosomal Proteins | 1 | 2018 | 22 | 0.040 |
Why?
|
| Chromatin | 1 | 2019 | 186 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1124 | 0.030 |
Why?
|
| Drug Design | 1 | 2019 | 186 | 0.030 |
Why?
|
| Hydroxylation | 1 | 2016 | 12 | 0.030 |
Why?
|
| Crystallization | 1 | 2016 | 88 | 0.030 |
Why?
|
| Electron Transport | 1 | 2016 | 47 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 220 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 457 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2019 | 735 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 1410 | 0.030 |
Why?
|
| Boron | 1 | 2013 | 10 | 0.030 |
Why?
|
| Anions | 1 | 2013 | 44 | 0.030 |
Why?
|
| Neoplasms | 1 | 2024 | 1377 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1070 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 53 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2011 | 68 | 0.020 |
Why?
|
| Iron | 1 | 2013 | 251 | 0.020 |
Why?
|
| Cholinergic Antagonists | 1 | 2006 | 10 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2006 | 44 | 0.010 |
Why?
|
| Ion Channel Gating | 1 | 2006 | 82 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2006 | 229 | 0.010 |
Why?
|
| Temperature | 1 | 2006 | 313 | 0.010 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2004 | 35 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 97 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 102 | 0.010 |
Why?
|
| Amides | 1 | 2004 | 71 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 611 | 0.010 |
Why?
|